200 related articles for article (PubMed ID: 26463340)
1. Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples.
Noberini R; Uggetti A; Pruneri G; Minucci S; Bonaldi T
Mol Cell Proteomics; 2016 Mar; 15(3):866-77. PubMed ID: 26463340
[TBL] [Abstract][Full Text] [Related]
2. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samples.
Noberini R; Longuespée R; Richichi C; Pruneri G; Kriegsmann M; Pelicci G; Bonaldi T
Clin Epigenetics; 2017; 9():69. PubMed ID: 28702092
[TBL] [Abstract][Full Text] [Related]
3. [Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modifications].
Tian S; Liu R; Qian X; Guo X; Zhang K
Se Pu; 2021 Oct; 39(10):1094-1101. PubMed ID: 34505431
[TBL] [Abstract][Full Text] [Related]
4. A Super-SILAC Strategy for the Accurate and Multiplexed Profiling of Histone Posttranslational Modifications.
Noberini R; Bonaldi T
Methods Enzymol; 2017; 586():311-332. PubMed ID: 28137569
[TBL] [Abstract][Full Text] [Related]
5. Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach.
Noberini R; Pruneri G; Minucci S; Bonaldi T
Data Brief; 2016 Jun; 7():188-94. PubMed ID: 27408908
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approach.
Bonaldi T; Noberini R
Expert Rev Proteomics; 2016; 13(3):245-50. PubMed ID: 26822344
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of histones from patient samples for mass spectrometry-based analysis of post-translational modifications.
Noberini R; Restellini C; Savoia EO; Bonaldi T
Methods; 2020 Dec; 184():19-28. PubMed ID: 31605746
[TBL] [Abstract][Full Text] [Related]
8. Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS.
Bauden M; Kristl T; Andersson R; Marko-Varga G; Ansari D
Lab Invest; 2017 Mar; 97(3):279-288. PubMed ID: 27941757
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer.
Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
[TBL] [Abstract][Full Text] [Related]
10. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
11. hSWATH: Unlocking SWATH's Full Potential for an Untargeted Histone Perspective.
De Clerck L; Willems S; Noberini R; Restellini C; Van Puyvelde B; Daled S; Bonaldi T; Deforce D; Dhaenens M
J Proteome Res; 2019 Nov; 18(11):3840-3849. PubMed ID: 31429292
[TBL] [Abstract][Full Text] [Related]
12. Improved bottom-up strategy to efficiently separate hypermodified histone peptides through ultra-HPLC separation on a bench top Orbitrap instrument.
Soldi M; Cuomo A; Bonaldi T
Proteomics; 2014 Oct; 14(19):2212-25. PubMed ID: 25073962
[TBL] [Abstract][Full Text] [Related]
13. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
Krautkramer KA; Reiter L; Denu JM; Dowell JA
J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
[TBL] [Abstract][Full Text] [Related]
14. Profiling post-translational modifications of histones in neural differentiation of embryonic stem cells using liquid chromatography-mass spectrometry.
Zheng S; Sun M; Zhang K; Gu J; Guo Z; Tian S; Zhai G; He X; Jin Y; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():36-44. PubMed ID: 26945132
[TBL] [Abstract][Full Text] [Related]
15. Alternative digestion approaches improve histone modification mapping by mass spectrometry in clinical samples.
Restellini C; Cuomo A; Lupia M; Giordano M; Bonaldi T; Noberini R
Proteomics Clin Appl; 2019 Jan; 13(1):e1700166. PubMed ID: 30471193
[TBL] [Abstract][Full Text] [Related]
16. Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped Human Histones Differ in Post-translational Modification Patterns.
Tvardovskiy A; Wrzesinski K; Sidoli S; Fey SJ; Rogowska-Wrzesinska A; Jensen ON
Mol Cell Proteomics; 2015 Dec; 14(12):3142-53. PubMed ID: 26424599
[TBL] [Abstract][Full Text] [Related]
17. Middle-down hybrid chromatography/tandem mass spectrometry workflow for characterization of combinatorial post-translational modifications in histones.
Sidoli S; Schwämmle V; Ruminowicz C; Hansen TA; Wu X; Helin K; Jensen ON
Proteomics; 2014 Oct; 14(19):2200-11. PubMed ID: 25073878
[TBL] [Abstract][Full Text] [Related]
18. Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
Steiner C; Tille JC; Lamerz J; Kux van Geijtenbeek S; McKee TA; Venturi M; Rubbia-Brandt L; Hochstrasser D; Cutler P; Lescuyer P; Ducret A
Mol Cell Proteomics; 2015 Oct; 14(10):2786-99. PubMed ID: 26149442
[TBL] [Abstract][Full Text] [Related]
19. Sequential Window Acquisition of all Theoretical Mass Spectra (SWATH) Analysis for Characterization and Quantification of Histone Post-translational Modifications.
Sidoli S; Lin S; Xiong L; Bhanu NV; Karch KR; Johansen E; Hunter C; Mollah S; Garcia BA
Mol Cell Proteomics; 2015 Sep; 14(9):2420-8. PubMed ID: 25636311
[TBL] [Abstract][Full Text] [Related]
20. Quantitative proteomic analysis of post-translational modifications of human histones.
Beck HC; Nielsen EC; Matthiesen R; Jensen LH; Sehested M; Finn P; Grauslund M; Hansen AM; Jensen ON
Mol Cell Proteomics; 2006 Jul; 5(7):1314-25. PubMed ID: 16627869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
